escherichia coli enoyl -acyl carrier protein reductase ( fabi ) … · 4 70 these include e. coli...
TRANSCRIPT
1
Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient 1
operation of a functional reversal of the β-oxidation cycle 2
3
Jacob E. Vicka, James M. Clomburg
a, Matthew D. Blankschien
a,*, Alexander Chou
a, Seohyoung 4
Kima, and Ramon Gonzalez
a,b,# 5
6
a Department of Chemical and Biomolecular Engineering, Rice University, Houston, TX, USA 7
b Department of Bioengineering, Rice University, Houston, TX, USA 8
9
J.E.V. and J.M.C. contributed equally to this work
10
* Current Address: BASF Corporation, 500 White Plains Rd, Tarrytown, NY, 10591, USA
11
12
# To whom correspondence should be addressed: 13
Department of Chemical and Biomolecular Engineering, 14
Rice University, 6100 Main Street, MS-362, 15
Houston, TX 77005, USA. 16
Phone: (713)-348-4893, Fax: (713) 348-5478 17
email: [email protected] 18
19
Running Title: FabI supports a functional reversal of the β-oxidation cycle 20
21
Keywords: β-oxidation reversal; enoyl-acyl carrier protein reductases; metabolic engineering; 22
synthetic biology; fuels and chemicals23
AEM Accepts, published online ahead of print on 19 December 2014Appl. Environ. Microbiol. doi:10.1128/AEM.03521-14Copyright © 2014, American Society for Microbiology. All Rights Reserved.
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
2
ABSTRACT 24
We recently used a synthetic/bottom-up approach to establish the identity of the four 25
enzymes composing an engineered functional reversal of the β-oxidation cycle for fuel and 26
chemical production in Escherichia coli (Clomburg et al. 2012. ACS Synth. Biol. 1:541-554). 27
While native enzymes that catalyze the first three steps of the pathway were identified, the 28
identity of the native enzyme(s) acting as the trans-enoyl-CoA reductase(s) remained unknown, 29
limiting the amount of product synthesized (e.g. 0.34 g/L butyrate) and requiring the 30
overexpression of a foreign enzyme (Euglena gracilis trans-enoyl-CoA reductase (TER)) to 31
achieve high titers (e.g. 3.4 g/L butyrate). Here we examine several native E. coli enzymes 32
hypothesized to catalyze the reduction of enoyl-CoAs to acyl-CoAs. Our findings indicate that 33
FabI, the native enoyl-acyl carrier protein (enoyl-ACP) reductase (ENR) from type II fatty acid 34
biosynthesis, possesses sufficient NADH-dependent TER activity to support the efficient 35
operation of a β-oxidation reversal. Overexpression of FabI proved as effective as egTER for the 36
production of butyrate and longer-chain carboxylic acids. In order to further demonstrate the role 37
of FabI during a -oxidation reversal, we investigated whether bacterial ENRs from other 38
families were able to complement a fabI deletion without promiscuous reduction of crotonyl-39
CoA. These characteristics from Bacillus subtilis FabL enabled ΔfabI complementation 40
experiments that conclusively established that FabI encodes the native enoyl-CoA reductase 41
activity that supports the β-oxidation reversal in E. coli. 42
43
44
45
46
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
3
INTRODUCTION 47
Recent advancements in synthetic biology and enzyme and metabolic engineering (1, 2) 48
are allowing for the development of an ever expanding array of microbial hosts for the 49
production of advanced fuels and industrially relevant chemicals (3, 4). Most efforts are now 50
focused on moving past the historically successful biofuels and industrial products, such as 51
ethanol (5), towards ‘drop-in’ fuels and additives that can be seamlessly incorporated into 52
existing infrastructure (4). The production of such molecules requires the synthesis of higher 53
chain length (C ≥ 4) products from 1-, 2- or 3-carbon metabolic intermediates and hence 54
pathways that can mediate the formation of carbon-carbon bonds. A variety of native and 55
engineered pathways have been utilized for this purpose, including the Clostridial n-butanol 56
pathway (6) isoprenoid biosynthesis (7, 8), the α-ketoacids pathway (9, 10) and fatty acid 57
biosynthesis (11, 12). 58
Among the aforementioned pathways, the bacterial type II fatty acid biosynthesis system 59
(FAB II) (13) is probably the most widely engineered and has been harnessed for the synthesis of 60
many products, including fatty acids (14), fatty acid methyl esters (15), fatty acid ethyl esters 61
(11, 16), fatty alcohols (11), and alkanes (12). At the core of the FAB II system is an elongation 62
cycle that uses discrete enzymes to catalyze each of its four steps. The cycle is initiated by the 63
condensation of malonyl-acyl carrier protein (ACP) with acyl-ACP, catalyzed by a 3-ketoacyl-64
ACP synthase. The resulting 3-ketoester is dehydrogenated by a 3-ketoacyl-ACP reductase 65
followed by the dehydration of the resulting 3-D-hydroxyacyl-ACP to trans-2-enoylacyl-ACP. 66
The enzymes catalyzing these three steps are relatively conserved among bacteria. However, at 67
least four different enoyl-ACP reductase (ENR) bacterial families (FabI, FabL, FabV, and FabK) 68
catalyze the last step of the cycle in which the trans-2-enoyl-ACP is reduced to an acyl-ACP. 69
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
4
These include E. coli FabI, Bacillus subtilis FabL, Vibrio cholerae FabV, and Enterococcus 70
faecalis FabK (17-20). Each elongation round uses malonyl-ACP as extender unit, and hence 71
requires the ATP dependent conversion of acetyl-CoA to malonyl-CoA. 72
As the FAB II system described above, the recently engineered functional reversal of the 73
β-oxidation cycle is based on an elongation cycle that includes condensation, dehydrogenation, 74
dehydration, and reduction steps (Fig. 1) (21, 22). However, the β-oxidation reversal operates 75
with coenzyme A (CoA) intermediates and directly uses acetyl-CoA for acyl-CoA chain 76
elongation through a non-decarboxylating condensation mechanism, characteristics that support 77
product synthesis at maximum carbon and energy efficiency. While the original implementation 78
of the -oxidation reversal required complex modifications to the regulatory network of the 79
metabolism of fatty acids and other global regulators (22), recent efforts have been successful in 80
using a synthetic approach to manipulate individual and defined components of the pathway 81
(21). This latter study was able to identify native enzymes that catalyze the first three steps of 82
the pathway (i.e. thiolases (AtoB and FadA), 3-hydroxyacyl-CoA dehydrogenase (FadB), and 83
enoyl-CoA hydratase (FadB)) whose overexpression lead to butyrate synthesis. However, the 84
identity of the native enzyme responsible for the reduction of enoyl-CoAs remained unknown 85
and improved product yields were only achieved when a foreign trans-enoyl-CoA reductase 86
(TER) was utilized, a family of enzymes not native to E. coli. The studies reported in this 87
manuscript examine several native E. coli enzymes that have the potential to catalyze the 88
reduction of enoyl-CoAs to acyl-CoAs and establish that FabI, the native ENR from FAB II, 89
encodes an NADH-dependent TER-like activity at levels that support the efficient operation of a 90
functional β-oxidation reversal. 91
92
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
5
MATERIALS AND METHODS 93
Strains, plasmids, and genetic methods. Genomic DNA from Enterococcus faecalis V583 94
(ATCC 700802), Bacillus subtilis (Ehrenberg) Cohn (ATCC 23857), and Vibrio cholerae 95
N16961 (ATCC 39315), and Megasphaera elsdenii Rogosa strain were acquired from ATCC 96
(Manassas, Virginia). Escherichia coli genomic DNA from MG1655 (23) and M. elsdenii 97
Rogosa were purified using the Wizard Genomic DNA Purification Kit (Promega, Madison, 98
WI). E. gracilis TER was amplified from a plasmid harboring a codon-optimized egTER 99
synthesized by GenScript (Piscataway, NJ). All restriction enzymes were purchased from New 100
England Biolabs (Ipswich, MA). Plates were prepared using LB medium containing 1.5% agar, 101
and appropriate antibiotics were included at the following concentrations when required: 102
ampicillin (100 µg/mL), kanamycin (50 µg/mL), spectinomycin (50 µg/mL), chloramphenicol 103
(12.5 µg/mL chromosomal/ 34 µg/mL plasmids) and zeocin (25-50 µg/mL). 104
Gene overexpression was achieved by cloning the desired gene(s) into either pETDuet-1 105
or pCDFDuet-1 (Novagen, Darmstadt, Germany) digested with NcoI and EcoRI restriction 106
enzymes utilizing In-Fusion PCR cloning technology (Clontech Laboratories, Inc., Mountain 107
View, CA). Cloning inserts were created via PCR of ORFs of interest from their respective 108
genomic or codon-optimized DNA (primers listed in Table 2) with Phusion DNA polymerase 109
(Thermo Scientific, Waltham, MA). The resulting In-Fusion products were used to transform E. 110
coli Stellar cells (Clontech Laboratories, Inc., Mountain View, CA) and PCR identified clones 111
were confirmed by DNA sequencing. All resulting plasmids used in this study are listed in Table 112
1. 113
Strain JC01 (MG1655 ldhA poxB pta adhE frdA) (21), a derivative of wild-type 114
K12 Escherichia coli strain MG1655, was used as the host for all genetic modifications. 115
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
6
JC01(DE3) was constructed from JC01 using a λDE3 Lysogenization Kit (Novagen, Darmstadt, 116
Germany) to allow the expression of genes under the T7 lac promoter. Gene knockouts were 117
introduced in JC01(DE3) and its derivatives by P1 phage transduction (24, 25). Single gene 118
knockout mutants from the National BioResource Project (NIG, Japan) (26) were used as donors 119
of specific mutations with the exception of fabI. ΔfabI was first constructed in strain HME45 120
(27) harboring pCA24N-fabI from the ASKA collection (28) and 10 µM Isopropyl β-D-1-121
thiogalactopyranoside (IPTG) to ensure expression of FabI from the vector. FRT-Kan-FRT with 122
homology to FabI was amplified from the pKD4 plasmid (29) and transformed into HME45 123
[pCA24N-fabI] selecting on kanamycin or chloramphenicol plates with 10 µM IPTG for gene 124
expression. The resulting HME45 ΔfabI::FRT-Kan-FRT [pCA24N-fabI] was then used for P1 125
phage transduction to produce ΔfabI strains. All mutations were confirmed by polymerase chain 126
reaction and the disruption of multiple genes in a common host was achieved as previously 127
described (25). All resulting strains used in this study are listed in Table 1. 128
Strain JC01(DE3) was further modified to allow for cumate inducible control (30) from 129
the genome. To enable this, the construction of pUCBB-pCT5-ntH6-eGFP (Sequence and Map 130
in Supplementary Figure S1 and Table S1) was first completed based on previous BioBrickTM
131
vector designs (31). E. coli atoB and fadB genes were PCR amplified and digested with BglII 132
and NotI and ligated by T4 ligase (Invitrogen, Carlsbad, CA) into pUCBB-PCT5
-ntH6-eGFP that 133
was previously digested with BglII and NotI to produce pUCBB- PCT5
-atoB and pUCBB- PCT5
-134
fadB. The resulting ligation products were used to transform E. coli DH5α (Invitrogen, 135
Carlsbad, CA) and positive clones identified by PCR were confirmed by DNA sequencing. To 136
integrate the cumate-controlled atoB and fadB constructs onto the chromosome, first the cumate 137
repressor (cymR), promoter/operator regions (PCT5
), and respective ORFs were PCR amplified, 138
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
7
as well as kanamycin or chloramphenicol drug constructs (respectively via pKD4 and pKD3 139
(29)). These respective products were linked together via overlap extension PCR to create a final 140
chromosomal targeting construct. Integration of the cumate-controlled constructs was achieved 141
via standard recombineering protocols using strain HME45 and selecting on respective LB drug 142
plates (32). The fadA gene was separately deleted via recombineering in the HME45 derivative 143
harboring the cumate-controlled fadBA construct by replacement of the fadA ORF with a zeocin-144
resistance marker amplified from pKDzeo (33). All constructs were verified via PCR and 145
sequencing. All construction primers are listed in Table 2. 146
147
Culture medium and cultivation conditions. The medium designed by Neidhardt et al. (34), 148
with 125 mM MOPS and Na2HPO4 in place of K2HPO4, supplemented with 20 g/L glycerol, 10 149
g/L tryptone, 5 g/L yeast extract, 100 µM FeSO4, 5 mM calcium pantothenate, 1.48 mM 150
Na2HPO4, 5 mM (NH4)2SO4, and 30 mM NH4Cl was used for all fermentations. Antibiotics (50 151
µg/mL carbenicillin and 50 µg/mL spectinomycin) and inducers (5 µM Isopropyl β-D-1-152
thiogalactopyranoside and 0.1 mM cumate) were included when appropriate. All chemicals were 153
obtained from Fisher Scientific Co. (Pittsburg, PA) and Sigma-Aldrich Co. (St. Louis, MO). 154
Fermentations were conducted under microaerobic conditions similar to those used in 155
previous studies (21, 22, 35). 25 mL Pyrex Erlenmeyer flasks (narrow mouth/heavy duty rim, 156
Corning Inc., Corning, NY) were filled with 20 mL of the above culture medium and sealed with 157
foam plugs filling the necks. A single colony of the desired strain was cultivated overnight (14-158
16 hrs) in LB medium with appropriate antibiotics and used as the inoculum (1%) for all 159
fermentations. After inoculation, flasks were incubated at 37°C and 200 rpm in an NBS C24 160
Benchtop Incubator Shaker (New Brunswick Scientific Co., Inc., Edison, NJ) until an optical 161
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
8
density of ~0.3-0.5 was reached, at which point IPTG and cumate were added. Flasks were then 162
incubated under the same conditions for 48 hrs post-induction unless otherwise stated. 163
164
Enzymatic characterization and assays. For measurement of enzymatic activities from 165
fermentation samples, cells were disrupted using glass beads as previously reported (22). HIS 166
Tagged FabI protein was harvested from BL21(DE3) cells (New England Biolabs, Ipswitch, 167
MA) containing pCA24N-fabI, induced with 0.1 mM IPTG at an OD600nm ~0.4 and grown 168
overnight at room temperature in LB medium. Purification was conducted as previously reported 169
using Talon Metal Affinity Resin (Clontech Laboratories, Inc., Mountain View, CA) (21). 170
For AtoB and FadB, thiolase activity and β-hydroxybutyryl-CoA dehydrogenase activity 171
were monitored as previously described (21). Trans-enoyl-CoA reductase activity for egTER, 172
FabI, bsFabL, efFabK and vcFabV was monitored by loss of NADH at 340 nm as previously 173
described (21, 36). For the kinetic characterization of FabI, crotonyl-CoA concentrations 174
ranging from 100 to 7500 µM were utilized. Acyl-CoA dehydrogenase activity was monitored 175
by measuring the reduction of Methyl-thiazolyl blue (MTT) coupled to the oxidation of butyryl-176
CoA (37) in cellular extracts disrupted as above with the addition of 5 µM flavin adenine 177
dinucleotide (FAD). Reaction conditions were as follows: 25 mM Tris pH 7.5, 240 µM MTT, 1.7 178
mM phenazine methosulfate (PMS), 15 mM sodium cyanide, and 250 µM butyryl-CoA in a final 179
volume of 200 µL at 30 °C. All substrates and chemicals for enzyme assays were obtained from 180
Fisher Scientific Co. (Pittsburg, PA) and Sigma-Aldrich Co. (St. Louis, MO). 181
182
Analytical methods. Determination of cell growth, quantification of glycerol and metabolic 183
products by high-performance liquid chromatography (HPLC), quantification of carboxylic acids 184
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
9
by HPLC (C4, C5, C6) and Gas Chromatography-Flame Ionization Detection (GC-FID) (C7-185
C14) were performed as previously described (21). For quantification purposes of odd-chain 186
carboxylic acids, samples were run with and without the C13 carboxylic acid internal standard, 187
verifying that C13 was not produced. Propionic (C3:0), valeric (C5:0), enanthic (C7:0), pelargonic 188
(C9:0) and undecyclic (C11:0) acid (Sigma Chemical Co., St. Louis, MO) standards were used to 189
calibrate HPLC and GC-FID analysis. 190
High performance liquid chromatography-mass spectrometry (HPLC-MS) was performed 191
on a Bruker MicroTOP ESI (Fremont, CA) with an Agilent 1200 HPLC System (Santa Clara, 192
CA). Enzymatic reactions were quenched with 10 % of 1N HCl and diluted 10 fold with dH2O, 2 193
µL of which was used for injection. HPLC-MS assays were performed using a Shimadzu Shim-194
pack XR-ODS II column (2.0 mm I,d. x 75 mm) (Tokyo, Japan) at a flow rate of 0.15 mL/min 195
with a maximum pressure of 380 bar at room temperature. Liquid chromatography was 196
performed with 40 mM ammonium acetate (Buffer A) and methanol (Buffer B). The time course 197
was as follows: 0 min – 2.5% methanol, linear gradient to 70% methanol at 7 min, hold at 70% 198
methanol to 12 min, linear gradient to 2.5% methanol at 12.1 min, hold at 2.5% methanol to 24 199
min. 200
201
RESULTS 202
Chromosomal overexpression of the first three steps of the β-oxidation reversal: thiolase, 3-203
hydroxyacyl-CoA dehydrogenase and enoyl-CoA dehydratase. Previously, the identification 204
and overexpression of native thiolase (AtoB) and 3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA 205
hydratase (FadB) components resulted in the ability to produce small amounts of butyrate 206
through a one-turn -oxidation reversal (21). In order to establish a clean, vector-free platform 207
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
10
to identify the unknown native enzyme(s) that catalyze the final step of the -oxidation reversal, 208
we constructed a strain with tunable chromosomal expression of AtoB and FadB by engineering 209
their native chromosomal loci. Using an in-house developed expression system based on a 210
cumate-inducible promoter (30) adapted into a BioBrick vector system (31) (Supplemental 211
Information Figure S1, Table S1), genomic expression of the atoB and fadBA operons was 212
altered to be cumate-controlled. Both native promoters were replaced by the T5 promoter 213
controlled by the CymR operator (CT5) and an upstream constitutive expression system for 214
CymR. Prior to these modifications, strain JC01 was modified to include the DE3 cassette to 215
allow the use of Novagen’s Duet vector system for the expression of candidate enzymes. The 216
resulting strain will be referred to throughout the manuscript as JC01(DE3) atoBCT5
fadBACT5
. A 217
second strain, JC01(DE3) atoBCT5
fadBCT5
ΔfadA, was created by deleting fadA from the fadBA 218
operon. Since fadA encodes a long-chain thiolase, its deletion prevented operation of multiple 219
turns of the -oxidation reversal. This, in turn, enabled the use of butyrate production as proxy 220
for flux through a single turn reversal of the β-oxidation cycle in strain JC01(DE3) atoBCT5
221
fadBCT5
ΔfadA, facilitating the identification of native enzyme(s) responsible for the reduction of 222
crotonyl-CoA. 223
In order to verify that chromosomal expression of the thiolase (AtoB), 3-hydroxyacyl-224
CoA dehydrogenase (FadB), and enoyl-CoA dehydratase (FadB) supports product synthesis 225
from a β-oxidation reversal, enzyme activities and fermentation profiles of JC01(DE3) atoBCT5
226
fadBCT5
ΔfadA were compared to those of the vector-based expression system in strain 227
JC01(DE3) [pETDuet-atoB pCDFDuet-fadB]. The chromosomal expression strain produced 228
more butyrate (0.63 ± 0.01 g/L) and 3-hydroxybutyrate (4.33 ± 0.04 g/L) than the vector based 229
system (butyrate = 0.42 ± 0.03 g/L, 3-hydroxybutyrate = 3.23 ±0.07 g/L) (data not shown). The 230
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
11
chromosomal strain had similar 3-hydroxybutyryl-CoA dehydrogenase activity (2.2 ± 0.7 231
µmol/mg/min) to that of pCDFDuet-fadB (1.7 ± 0.7 µmol/mg/min) while thiolase activity was 232
greater from pETDuet-atoB (25.0 ± 3.2 µmol/mg/min) in comparison to atoB expression from 233
the chromosome (3.8 ± 0.3 µmol/mg/min). The higher product yield from JC01(DE3) atoBCT5
234
fadBCT5
ΔfadA indicates that adequate amounts of thiolase and 3-hydroxybutryl-CoA 235
dehydrogenase activities are produced by chromosomal expression. 236
237
Identification of native enzyme(s) responsible for conversion of crotonyl-CoA to butyryl-238
CoA in strain JC01(DE3) atoBCT5
fadBCT5
fadA. Multiple enzymes in E. coli have the 239
potential to reduce a 2,3-trans-enoyl-CoA (e.g. crotonyl-CoA) to the corresponding acyl-CoA 240
(e.g. butyryl-CoA). These include two acyl-CoA dehydrogenases (ACDH) from β-oxidation 241
pathways, FadE and YdiO. FadE is the aerobic ACDH (37, 38) while YdiO appears to be a 242
member of a butyryl-CoA dehydrogenase (BCD) electron transfer protein (Etf) complex 243
(BCD/EtfBA) necessary for growth on fatty acids under anaerobic conditions (39). Two other 244
ACDHs could reduce crotonyl-CoA as a promiscuous substrate; the crotonobetaine reductase 245
complex CaiAB (40, 41) and AidB, the isovaleryl-CoA dehydrogenase (42, 43). 246
The genes encoding the aforementioned ACDHs were deleted and overexpressed in strain 247
JC01(DE3) atoBCT5
fadBCT5
ΔfadA and their effect on butyrate production assessed. The 248
deletions had little impact on either butyrate or 3-hydroxybutyrate production levels and did not 249
impair growth (Fig. 2). The only ACDH over-expression that affected butyrate yield was FadE, 250
which resulted in a 44% increase in comparison to a control with the pETDuet vector alone (Fig. 251
2). Similarly, only the overexpression of FadE resulted in a change in measurable 252
dehydrogenase activity on butyryl-CoA with a specific activity of 0.019 ± 0.0017 µmol/mg/min, 253
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
12
which is an order of magnitude greater than any other tested (Table 3). Since deletion or 254
overexpression of ACDHs did not result in significant changes to butyrate levels when combined 255
with AtoB and FadB overexpression, alternative candidates for enzymes catalyzing the 256
conversion of crotonyl-CoA to butyryl-CoA were explored. 257
Given its reported ability to reduce crotonyl-CoA to butyryl-CoA, FabI, the essential 258
enoyl-ACP reductase (ENR) from the fatty acid biosynthesis pathway (44-46) was investigated. 259
When crude extracts from JC01(DE3) atoBCT5
fadBCT5
ΔfadA were assayed for NAD(P)H-260
dependent reduction of crotonyl-CoA, no detectable activity was measured (Table 3). This is not 261
necessarily an unexpected result, as FabI only reduces crotonyl-CoA as a promiscuous substrate 262
with a reported KM (2.7 mM) (17), which is roughly 30-fold higher than the concentration of 263
crotonyl-CoA (80 µM) used in the standard trans-enoyl-CoA reductase assay (21, 36). In assays 264
using 1 mM crotonyl-CoA, NADH-dependent crotonyl-CoA reduction activities of 0.100 ± 265
0.001 µmol/mg/min and 0.080 ± 0.007 µmol/mg/min were observed in crude cell extracts from 266
fermentation samples of JC01(DE3) atoBCT5
fadBCT5
ΔfadA harvested at 8 and 48 hours, 267
respectively (Table 3). These results suggested potential involvement of an NADH-dependent 268
TER-like enzyme in butyrate production from a one-turn reversal of the -oxidation cycle, which 269
based on previous studies, could be encoded by fabI. 270
To further investigate the potential role of FabI, vectors containing fabI or egTER were 271
constructed and transformed into JC01(DE3) atoBCT5
fadBCT5
ΔfadA to assess butyrate 272
production from a one-turn -oxidation reversal. As seen in Fig. 2, FabI over-expression resulted 273
in significant increase in butyrate production compared to that with only AtoB and FadB 274
expression. Even more surprising, the overexpression of FabI resulted in butyrate production at 275
levels comparable to egTER overexpression (3.66 g/L and 3.64 g/L, respectively), while also 276
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
13
showing similar reduction in 3-hydroxybutyrate levels (to 0.9 and 0.5 g/L respectively) (Fig. 2). 277
When comparing the trans-enoyl-CoA reductase activities of these fermentations samples (using 278
the standard 80 µM crotonyl-CoA), fabI-overexpressing cultures showed an activity which is six 279
times lower than the activity observed upon egTER-overexpression (Table 3). Despite these 280
lower levels of activity, the comparable levels of butyrate production with either fabI or egTER 281
overexpression demonstrates the potential of an enoyl-ACP reductase from the type II fatty acid 282
biosynthesis pathway to function with CoA intermediates in the context of a reversal of the -283
oxidation cycle. 284
In order to provide further evidence that promiscuous crotonyl-CoA reduction by FabI is 285
involved in a native -oxidation reversal, fabI deletion is required. Given the essential nature of 286
FabI (this enzyme is the only ENR in E. coli), construction of a ΔfabI strain requires 287
complementation with another trans-enoyl-ACP activity. Moreover, to verify the hypothesis that 288
FabI indeed functions as the enoyl-CoA reductase of the -oxidation reversal, the 289
complementing enoyl-ACP reductase should not promiscuously reduce crotonyl-CoA as well. 290
Since no enoyl-ACP reductase has been reported with these explicit characteristics, we 291
investigated the following representative members of bacterial ENR families for their lack of 292
crotonyl-CoA reductase activity: Bacillus subtilis FabL (bsFabL) (19), Enterococcus faecalis 293
FabK (efFabK) (18, 47), and Vibrio cholerae FabV (vcFabV) (20). 294
Genes encoding each of the aforementioned ENRs were cloned into pETDuet and the 295
resulting vectors transformed into JC01(DE3) atoBCT5
fadBCT5
ΔfadA, and the resulting strains 296
assayed for crotonyl-CoA reductase activity using 80 µM crotonyl-CoA. While detectable 297
activity was measured for cells with efFabK or vcFabV, no activity was detected for the cells 298
overexpressing bsFabL (Table 3). Even when assayed with 1 mM crotonyl-CoA, the levels of 299
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
14
crotonyl-CoA reductase activity shown by cell extracts of JC01(DE3) atoBCT5
fadBCT5
ΔfadA 300
ΔfabI [pETDuet-bsfabL] are similar to the background levels measured for JC01(DE3) atoBCT5
301
fadBCT5
ΔfadA [pETDuet], making bsfabL an ideal candidate to complement a fabI deletion 302
without also providing the ability to promiscuously reduce crotonyl-CoA. As such, JC01(DE3) 303
atoBCT5
fadBCT5
ΔfadA ΔfabI strains were constructed in the presence of either pETDuet-fabI or 304
pETDuet-bsfabL. These vectors complemented the fabI deletion equally well, as evidenced by 305
the isolation of viable transductions as well as the similar growth of both strains during 306
fermentations (Fig. 2). However, significant differences in butyrate production (Fig. 2) and 307
enoyl-CoA reductase activity (Table 3) were observed between the two strains. JC01(DE3) 308
atoBCT5
fadBCT5
ΔfadA ΔfabI [pETDuet-fabI] still produced large amounts of butyrate and 309
exhibited enoyl-CoA reductase activity, characteristics not observed with JC01(DE3) atoBCT5
310
fadBCT5
ΔfadA ΔfabI [pETDuet-bsfabL]. These results strongly support the hypothesis that FabI 311
is the unknown enzyme responsible for enoyl-CoA reduction in the experiments discussed above 312
and as such could also have played a role in product synthesis through previously engineered -313
oxidation reversal in E. coli (21, 22). 314
315
Kinetic characterization of FabI-encoded trans-enoyl-CoA reductase. The low catalytic 316
efficiency reported for FabI on crotonyl-CoA (kcat/KM = 8.52 x 101 M
-1 s
-1) is not only several 317
orders of magnitude lower than that reported with crotonyl-ACP (kcat/KM = 1.91 x 106
M-1
s-1
) 318
(17), but also contrasts with our observation that this enzyme supports butyrate synthesis fluxes 319
as high as those supported by egTER, an enzyme with a high catalytic efficiency on crotonyl-320
CoA (kcat/KM = 1.2 ± 0.1 M4 sec
-1) (21). A comparison of crotonyl-CoA reduction activity 321
observed in crude extracts of our cultures to the expected activity based on reported FabI kinetic 322
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
15
parameters (17) revealed an interesting picture. For example, after 8 hours of cultivation, strain 323
JC01(DE3) atoBCT5
fadBCT5
ΔfadA exhibited an NADH-dependent crotonyl-CoA reduction 324
activity (with 1 mM crotonyl-CoA) of 0.100 ± 0.001 µmol/mg/min, which corresponds to an 325
observed rate of 4.88 x 10-8
M s-1
. The total protein concentration of the same culture was 2.94 326
mg/mL, from which the concentration of FabI is estimated to be between 6.83 x 10-8
M and 6.83 327
x 10-12
M (48). Considering this concentration of FabI in the crude protein extract, the reported 328
kcat (0.23 s-1
) and KM (2.7 mM) (17), and the 1 mM crotonyl-CoA concentration utilized in the 329
measurement of the specific activities, the expected rate of crotonyl-CoA reduction by FabI in 330
the crude protein extract was calculated to be between 7.86 x 10-13
M s-1
and 7.86 x 10-9
M s-1
. 331
These calculations indicate that the expected rate obtained from reported kinetic parameters is 332
only a very small fraction of the rate observed in our cultures, which warrants re-evaluation of 333
the kinetic parameters of FabI using crotonyl-CoA as the substrate. 334
N-terminal His-tagged FabI was purified from BL21(DE3) containing an ASKA 335
collection vector expressing fabI (29). The purified enzyme had a KM (4.6 ± 0.6 mM) quite 336
similar to the reported KM of 2.7 mM (17), but our measurement of kcat was 5.3 ± 0.6 s-1
in 337
comparison to the previously reported 0.23 s-1
, resulting in a 13-fold improvement of catalytic 338
efficiency (kcat/KM) from 8.52 x 101 M
-1 s
-1 to 1.15 x 10
3. This change in kcat increases the 339
expected rate of crotonyl-CoA reduction by FabI to a value between 1.02 x 10-7
M s-1
and 7.86 x 340
10-11
M s-1
, which is in agreement with the rate observed in our cultures. 341
To verify that FabI is utilizing NADH to convert crotonyl-CoA to butyryl-CoA, the 342
reaction was monitored via HPLC-MS, which confirmed that FabI converts crotonyl-CoA almost 343
completely to butyryl-CoA (Fig. 3A). Factors such as the presence of Mg2+
during our 344
purification as well as Tris-HCl vs. phosphate based buffer systems had marginal effect on 345
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
16
activity levels (data not shown). The most likely cause for the discrepancy in measured kcat is that 346
previous studies (17) used a maximum of approximately 1.25 mM crotonyl-CoA, which is less 347
than their reported KM indicating that there was not an accurate estimation of Vmax during their 348
measurements. 349
As an essential gene for fatty acid biosynthesis, FabI is inhibited when large amounts of 350
palmitic acid (C16) are present (Ki of 5.4 µM towards palmitoyl-ACP and 20 µM towards 351
palmitoyl-CoA), but this inhibition is quickly lost for shorter fatty acids as the Ki for decanoyl-352
CoA is approximately 900 µM (45). In order to understand the potential of utilizing FabI for a 353
functional reversal of β-oxidation in E. coli, we examined the effect of key CoA thioester 354
intermediates of the -oxidation reversal as well as a broad range of acyl-CoAs on FabI activity 355
(Fig. 3C). As expected, palmitoyl-CoA demonstrated close to 50% inhibition at 20 µM, while 356
myristoyl-CoA (C14) had the highest percent inhibition at 200 µM. The shorter-chain and -357
functionalized acyl-CoAs thioesters, acetoacetyl-CoA and 3-hydroxybutyryl-CoA demonstrated 358
minimal inhibitory effects. The pH range for FabI activity was also examined for comparison to 359
the reported profile for crotonyl-ACP (46) (Fig. 3B). Using crotonyl-CoA, FabI shows activity 360
over a broad range of pH (4.75 to 9.5). This range is not dissimilar to the reported pH range with 361
crotonyl-ACP, although the optimal pH switched to pH 8.5 and the enzyme remained active at 362
higher pHs. 363
364
FabI supports the synthesis of longer-chain (C>4) carboxylic acids. As previously 365
mentioned, employing AtoB as the thiolase in the -oxidation reversal limits the operation of the 366
pathway to one cycle and product synthesis to 4-C molecules. By including FadA, which has 367
longer chain length specificity, the production of longer chain products is possible. When fabI is 368
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
17
overexpressed from pETDuet in JC01(DE3) atoBCT5
fadBACT5
, the production of extracellular 369
longer chain length carboxylic acids is observed (Fig. 4A). The most abundant longer chain 370
produced is C6 (0.53 ± 0.03 g/L), while C8, C10 and C12 carboxylic acids are produced at 57.8 371
± 4.7, 56.8 ± 4.4 and 11.5 ± 0.3 mg/L, respectively (Fig. 4A). 372
The deletion of fadD, encoding an acyl-CoA synthetase, has been utilized in numerous 373
studies to facilitate the accumulation of longer chain carboxylic acids by preventing the 374
uptake/activation of free fatty acids (14). Under these conditions, the deletion of fadD in 375
JC01(DE3) atoBCT5
fadBACT5
with pETDuet-fabI resulted in the extracellular production of 19.4 376
± 0.1 mg/L tetradecanoic acid (C14) and a slight increase in dodecanoic acid (C12), with 377
minimal impact on the levels of C4-C10 carboxylic acids produced (Fig. 4A). In order to alter 378
the product profile away from C4 and C6 carboxylic acids, yciA, encoding a thioesterase 379
previously shown to have a marked effect on short chain product profiles (21), was also deleted. 380
This resulted in significant increases to C8 (97.4 ± 1.9 mg/L) and C10 (102.5 ± 8.0 mg/L) 381
carboxylic acids while greatly reducing the amount of butyrate (0.47 ± 0.01 g/L) (Fig. 4A). 382
In order to investigate the potential for FabI to be used in the production odd-chain 383
carboxylic acids, strain JC01(DE3) atoBCT5
fadBACT5
ΔfadD ΔyciA was further complemented 384
with the propionate CoA transferase (PCT) from M. elsdenii (49), which has been used to 385
successfully produce a variety of C5 carboxylic acid molecules (50). mePCT was cloned into the 386
pCDFDuet vector to facilitate co-expression with pETDuet-fabI. JC01 (DE3) atoBCT5
fadBACT5
387
ΔfadD ΔyciA was co-transformed with these two vectors to determine odd chain carboxylic acid 388
production in the presence of 15 mM propionate. This strain produced odd chain carboxylic 389
acids ranging from 187 ± 4 mg/L of valerate (C5) to a maximum chain length of C11 at 30.9 ± 390
0.6 mg/L (Fig. 4B). 391
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
18
392
FabI enables product synthesis via a functional reversal of the β-oxidation cycle not the 393
type II fatty acid biosynthesis pathway. Considering the use of an enzyme from the type II 394
fatty acid biosynthesis pathway, it stands to reason that product synthesis (e.g. butyrate and other 395
products) could proceed through this pathway, instead of a -oxidation reversal. Fortunately, the 396
condensation reactions responsible for carbon chain elongation in these two pathways are very 397
different, providing an opportunity to clearly distinguish them. The -oxidation reversal uses 398
thiolases, which employ acetyl-CoA as the extender unit and a non-decarboxylating 399
condensation mechanism (51, 52). The fatty acid biosynthesis pathway uses keto-acyl-ACP 400
synthases, which employ a decarboxylating condensation mechanism and malonyl-ACP as the 401
extender unit (53). 402
Overexpression of FabI in strain JC01(DE3) resulted predominantly in the production of 403
acetate, a fermentation profile essentially undistinguishable from that of JC01(DE3) carrying the 404
empty pETDuet vector (Fig. 5). In fact, butyrate production with FabI expression was only 405
observed when a thiolase (AtoB or FadA) was used in conjunction with FadB (Fig. 5). The 406
requirement of a non-decarboxylating condensation enzyme (e.g. thiolases AtoB or FadA), as 407
well as the β-oxidation enzyme FadB to observe the synthesis of butyrate indicates that FabI is 408
facilitating a reversal of the β-oxidation cycle despite being an enzyme of the type II fatty acid 409
biosynthesis pathway. 410
411
DISCUSSION 412
While we previously identified native enzymes responsible for the thiolase (AtoB, FadA), 413
3-hydroxyacyl-CoA dehydrogenase (FadB), and enoyl-CoA dehydratase (FadB) components of a 414
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
19
functional reversal of the -oxidation cycle in E. coli, the identity of the enoyl-CoA reductase 415
component remained elusive (21). Here, FabI, the fatty acid type II enoyl-ACP reductase, was 416
identified as the primary enzyme responsible for enoyl-CoA reduction. FabI, though being less 417
kinetically efficient than egTER for the NADH dependent reduction of crotonyl-CoA, enabled -418
oxidation reversal fluxes similar to those supported by egTER. FabI also facilitated the 419
production of longer chain carboxylic acids when a second longer chain specific thiolase, FadA, 420
was present, and with the inclusion of propionyl-CoA transferase to synthesize the odd-chain 421
priming molecule propionyl-CoA, odd-chain carboxylic acids could also be produced. 422
In addition to providing a defined set of native enzymes that facilitate the functional 423
reversal of the -oxidation cycle, the use of an NADH-dependent enzyme as the enoyl-CoA 424
reductase has clear advantages for product synthesis. When comparing the standard free energies 425
resulting from full one-turn reversal, the cofactor utilized for electron transfer by the enoyl-CoA 426
reductase has a pronounced impact on the overall favorability of the pathway (Fig. 1). For 427
example, with the use of an enzyme dependent on ubiquinone for electron transfer, such as FadE, 428
the overall reversal of the pathway is unfavorable from a free energy standpoint. On the other 429
hand, with the use of either a ferredoxin- or NADH-dependent enzyme for the enoyl-CoA 430
reduction, operation of the β-oxidation pathway in the reverse direction becomes favorable under 431
standard conditions. These principles can help explain our results indicating that while slight 432
increases to butyrate production are observed upon overexpression of fadE with atoB and fadB, 433
the use of an NADH-dependent enzyme (e.g. FabI or egTER) results in dramatic increases in 434
product formation resulting from a full one-turn β-oxidation reversal (Fig. 2). While a 435
ferredoxin-dependent enzyme, such as YdiO, also has the potential to improve the overall 436
thermodynamics of the pathway, the paucity of ferredoxin-dependent reactions in E. coli results 437
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
20
in an effectively coupled reaction step. Unlike the use of NADH, which can be regenerated 438
through numerous metabolic reactions, the regeneration of a reduced ferredoxin requires the use 439
of a pyruvate ferredoxin oxidoreductase (54) during the conversion of pyruvate to acetyl-CoA. 440
This can have a pronounced impact on overall redox balance, as the requirement for the 441
generation of an additional reducing equivalent through this step can lead to an accumulation of 442
reducing equivalents during the synthesis of certain products (55). Thus, un-coupling the enoyl-443
CoA reduction from both thermodynamic and stoichiometric constraints through the use of an 444
NADH-dependent enzyme, such as FabI, can greatly increase the ability of a functional reversal 445
of the β-oxidation cycle to produce all potential products at a higher theoretical yield. 446
Despite the lower catalytic efficiency and specific activitiy of crotonyl-CoA reduction 447
with the use of FabI in comparison to egTER, the titers and yields of carboxylic acids produced 448
from a -oxidation reversal were similar with either enzyme. Based on this evidence, it is likely 449
that further improvements to pathway efficiency and product synthesis can achieved through 450
identifying potential bottlenecks at other pathway nodes. One key area that has not been 451
explored in detail is the role termination pathways play in product synthesis, as the production of 452
carboxylic acids in this case relies on endogenous enzymes for the conversion of acyl-CoA 453
intermediates into acid products. Considering the impact the deletion of yciA has on short and 454
medium chain carboxylic acid production, the manipulation of additional thioesterases is 455
envisioned as a means to improve not only product titers and yields, but also the selectivity of 456
product chain length. A similar approach with additional types of termination pathways, such as 457
acyl-CoA reductases for alcohol production, can also be utilized to diversify product synthesis. 458
In addition to the production of carboxylic acids and n-alcohols through the tailoring of 459
termination pathways, the promiscuous nature of ENRs can potentially be further exploited 460
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
21
within the context of a β-oxidation reversal through the use of various priming molecules, which 461
can lead to the synthesis of a diverse set of products with a wide range of functional groups (55). 462
463
ACKNOWLEDGEMENTS 464
This work was supported by grants from the U.S. National Science Foundation (EEC-0813570, 465
CBET-1134541, CBET-1067565). 466
467
FIGURE CAPTIONS 468
Figure 1. Engineered functional reversal of the β-oxidation cycle. Core enzymes consist of 469
thiolases (AtoB, FadA), hydroxyacyl-CoA dehydrogenase (FadB), enoyl-CoA hydratase (FadB), 470
and enoyl-CoA reductase (FabI, FadE). Enoyl-CoA reductase step highlighted in gray. 471
Thioesterases are shown as an example of termination enzymes that can act on CoA thioester 472
intermediates of the core pathway to generate carboxylic acids as the products. Free energies 473
were calculated as previously described (22) and assuming different redox partners for the enoyl-474
CoA reductase reaction. ΔGr values calculated assuming standard conditions (298.15 K, pH 7) 475
with minimum and maximum values (in parenthesis) calculated using minimum and maximum 476
metabolite concentrations set to 0.00001 M and 0.02 M, respectively. 477
478
Figure 2. Impact of deletion and over-expression of genes encoding enzymes potentially 479
responsible for the reduction of crotonyl-CoA on cell growth and product synthesis by strain 480
JC01(DE3) atoBCT5
fadBCT5
ΔfadA. Chromosomal gene deletions (“gene”) or plasmid based 481
(vector pETDuet) gene overexpression are indicated. Strain JC01 is a fermentation-deficient 482
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
22
derivate of E. coli MG1655 containing the following gene deletions: ldhA, poxB, pta, 483
adhE, and frdA. 484
485
Figure 3. Characterization of crotonyl-CoA reduction to butyryl-CoA by FabI. A. Mass 486
spectrum analysis of FabI reduction of crotonyl-CoA to butyryl-CoA. (i) Controls of crotonyl-487
CoA (836.3 m/z – gray) and butyryl-CoA (838.3 m/z – black). (ii) Reaction mixture without 488
FabI. (iii) Reaction mixture with FabI. B. pH activity profile of FabI with crotonyl-CoA and 489
NADH relative to pH 7.5 (1.0). C. Inhibition profile of crotonyl-CoA reduction activity for FabI 490
with the indicated CoA thioesters at either 20 or 200 µM relative to activity in absence of 491
inhibitor (100%). 492
493
Figure 4. Synthesis of longer chain carboxylic acids via multiple turns of a functional β-494
oxidation reversal using FabI as the enoyl-CoA reductase. A. Both short-chain (AtoB) and long-495
chain (FadA) thiolases were activated in strain JC01(DE3) atoBCT5
fadBACT5
to facilitate 496
operation of several turns of the β-oxidation reversal. The impact of deletion of fadD and yciA 497
on product synthesis is also shown. Gene deletion represented by “gene”. All strains included 498
either pETDuet or pETDuet-fabI (indicated by fabI+) vector. B. Production of odd chain 499
carboxylic acids is facilitated in strain JC01(DE3) atoBCT5
fadBACT5
ΔfadD ΔyciA pETDuet-fabI 500
when mePCT is co-expressed from pCDFDuet and the medium is supplemented with 15 mM 501
propionic acid. All strains and plasmids described in Table 1. 502
503
Figure 5. Cell growth and product synthesis for strain JC01(DE3) and its derivatives 504
demonstrating the FabI-mediated production of carboxylic acids proceeds through a functional 505
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
23
reversal of the β-oxidation cycle. Modifications to JC01(DE3) are indicated by either a gene 506
deletion (“gene”) or overexpression (chromosome or vector pETDuet). 507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
24
TABLES 529
Table 1. Strains and plasmids used in this study 530
Strain/Plasmid Description/Genotype Source
MG1655 F- - ilvG- rfb-50 rph-1 (23)
HME45 W3110 ΔlacU169 c1857 Δ(cro-bioA) (27)
HME45 ΔfabI pCA24N-fabI ‘HME45’ Δfabi::FRT-Kan-FRT pCA24N-fabI This Study
JC01 ‘MG1655’, ldhA::FRT poxB::FRT pta::FRT adhE::FRT frdA::FRT
sequential deletion of ldhA, poxB, pta, adhE, and frdA (21)
JC01 (DE3) JC01 harboring a λDE3 Lysogen This Study
JC01 (DE3) atoBCT5 ‘JC01 (DE3)’ FRT-cymR-PCT5-atoB This Study
JC01 (DE3) fadBACT5 ‘JC01 (DE3)’ FRT-cymR-PCT5-fadBA This Study
JC01 (DE3) fadBCT5 ΔfadA ‘JC01 (DE3)’ FRT-cymR-PCT5-fadB fadA::zeo This Study
JC01 (DE3) atoBCT5 fadBACT5 ‘JC01 (DE3) fadBACT5 ’ FRT-cymR-PCT5-atoB This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA 'JC01 (DE3) fadBCT5 ΔfadA’ FRT-cymR-PCT5-atoB This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔfabI
pETDuet-P1-fabI
‘JC01 (DE3) atoBCT5 fadBCT5 ΔfadA’ ΔfabI::FRT-Kan-FRT pETDuet-P1-
fabI This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔfabI
pETDuet-P1-bsfabL
‘JC01 (DE3) atoBCT5 fadBCT5 ΔfadA’ ΔfabI::FRT-Kan-FRT pETDuet-P1-
bsfabL This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔfadE ‘JC01 (DE3) atoBCT5fadBCT5 ΔfadA’ ΔfadE::FRT-Kan-FRT This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔydiO ‘JC01 (DE3) atoBct5 fadBct5 ΔfadA’ ΔydiO::FRT-Kan-FRT This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔcaiA ‘JC01 (DE3) atoBct5 fadBct5 ΔfadA’ ΔcaiA::FRT-Kan-FRT This Study
JC01 (DE3) atoBCT5 fadBCT5 ΔfadA ΔaidB ‘JC01 (DE3) atoBct5 fadBct5 ΔfadA’ ΔaidB::FRT-Kan-FRT This Study
JC01 (DE3) atoBCT5 fadBACT5 ΔfadD ‘JC01 (DE3) atoBCT5 fadBACT5’ fadD::FRT This Study
JC01 (DE3) atoBCT5 fadBACT5 ΔfadD ΔyciA ‘JC01 (DE3) atoBCT5 fadBACT5 ΔfadD’ yciA::FRT This Study
pCA24N-fabI pBR322-derived derived vector, oriR f1, cat ,lacIq, E coli fabI under T5lac
promoter (28)
pETDuet pETDuet-1 (pBR322-derived), oriR f1, lacI, bla Novagen
pETDuet-P1-egTER Euglena gracilis TER gene under T7lac promoter and lacI control This Study
pETDuet-P1-fabI E. coli fabI gene under T7lac promoter and lacI control This Study
pETDuet-P1-fadE E. coli fadE gene under T7lac promoter and lacI control This Study
pETDuet-P1-caiA E. coli caiA gene under T7lac promoter and lacI control This Study
pETDuet-P1-ydiO E. coli ydiO gene under T7lac promoter and lacI control This Study
pETDuet-P1-effadK E. faecalis V583 (ATCC 700802) fabK gene under T7lac promoter and lacI
control This Study
pETDuet-P1-bsfabL B. subtilis (ATCC 23857) fabL gene under T7lac promoter and lacI control This Study
pETDuet-P1-vcfabV V. cholerae (ATCC 39315) fabV gene under T7lac promoter and lacI control This Study
pCDFDuet pCDFDuet-1 (CloDF13-derived), oriR CDF, lacI, SmR Novagen
pCDFDuet-P1-mePCT M. elsdenii PCT gene under T7lac promoter and lacI control This Study
pCDFDuet-P1-fadB E. coli fadB gene under T7lac promoter and lacI control This Study
pUCBB- PCT5-ntH6-eGFP pUCBB-ntH6-eGFP derived vector eGFP gene under T5 promoter with an N-
Terminal His-Tag and cymR control This Study
pUCBB- PCT5-atoB E. coli atoB gene under T5 promoter and cymR control This Study
pUCBB- PCT5-fadB E. coli fadB gene under T5 promoter and cymR control This Study
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
25
Table 2. Primers used in this study for plasmid construction or chromosomal integrations. For 531
further details, see Materials and Methods section. 532
533
534
535
Constructs Primer Primer Sequences (5’-3’)
Plasmid
pETDuet-P1-egTER pNova-P1-egTER-L aggagatataccatggcaatgtttaccacgac
pNova-P1-egTER-R cgccgagctcgaattcttattgctgtgctgcggac
pETDuet-P1-fabI fabIFusNcoI5p aggagatataccatgggttttctttccggtaagcgcattctg
fabIFusEcoRI3p cgccgagctcgaattcttatttcagttcgagttcgttcattgc
pETDuet -P1-fadE fadEfus5p aggagatataccatgatgatgattttgagtattctcgctacg
fadEfusEcorRI3p cgccgagctcgaattcttacgcggcttcaactttccgcactttc
pETDuet -P1-caiA pNOVA-P1-caiA-L aggagatataccatggattttaatttaaatgatgagcag
pNOVA-P1-caiA-R cgccgagctcgaattccggacttagcggtattgctt
pETDuet-P1-effadK effabkncoduetfus5p aggagatataccatgaagtgtacttatcttagaactaaaggacg
effabkecorduetfus3p cgccgagctcgaattcttagccccaacgctgattcatcttatgtac
pETDuet-P1-bsfabL bsFabLfusNCO5p aggagatataccatggaacaaaataaatgtgcactcg
bsFabLfusECOR3p gccgagctcgaattcgttaaacgagcagtgagcgtccgcc
pETDuet-P1-vcfabV vcFabVfus5p aggagatataccatgatcatcaaacctaaaattcgtgg
vcFabVfusECO3p gccgagctcgaattcgttactcgatatcaatcacatcaaattcgacttctggattgacg
pCDFDuet-P1-mePCT pNova-P1-mePCT-L aggagatataccatgagaaaagtagaaatcattacagct
pNova-P1-mePCT-R cgccgagctcgaattcttattttttcagtcccatggg
pCDFDuet-P1-fadB pNova-P1-fadB-L aggagatataccatgctttacaaaggcgacacc
pNova-P1-fadB-R cgccgagctcgaattcttaagccgttttcaggtcgc
Chromosomal
FRT-cat-FRT-cymR-PCT5-
fadBA cat-homPepQ-L gcacatcgttcatccagagcgtgatttctgccgagcgtgatcagatcggcgtgtaggctggagctgcttcg
cat-ovcymfadB-R tctgaaattctgcctcgtgacatatgaatatcctcctta
cym-pCTC-fadB-ovcat-L taaggaggatattcatatgtcacgaggcagaatttcaga
fadBhom-R ttaactgaacctggggcatc
FRT-Kan-FRT-cymR-
PCT5-atoB kan-homatoE-L ttggtttaacgctgttctgacggcacccctacaaacagaaggaatataaacatatgaatatcctcctta
kan-ovcymatoB-R tctgaaattctgcctcgtgagtgtaggctggagctgcttcg
cym-pCTC-atoB-ovkan-L cgaagcagctccagcctacactcacgaggcagaatttcaga
atoBintrecomb-R gccagcccgctttttaac
ΔfabI::FRT-Kan-FRT deltaFabI-L cgcctgattttcaggcacaacaagcatcaacaataaggattaaagctatggtgtaggctggagctgcttcg
deltaFabI-R aacgccgcccatctttaccaacagaacgattatttcagttcgagttcgttcatatgaatatcctcctta
fadA::zeo deltafadAzeo-L ttgagccagcccgtccggttggcgacctgaaaacggcttaaggagtcacaatggccaagttgaccagtg
deltafadAzeo -R ttaaacccgctcaaacaccgtcgcaataccctgacccagaccgatacacatcagtcctgctcctctgc
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
26
Table 3. Impact of deletion/overexpression of acyl-CoA dehydrogenase or trans-enoyl-CoA 536
reductase encoding genes on respective enzymatic activities. 537
Strain Vector
Enzyme activity (μmol/mg protein/min)a
Acyl-CoA dehydrogenase NADH-Dependent
Trans-enoyl-CoA reductase
Crotonyl-CoA concentrationb
80 µM 1 mM
JC01(DE3) atoBCT5 fadBCT5 ΔfadA pETDuet (8 hours) 0.0034 ± .0001 n.d.c 0.10 ± .001
pETDuet (48 hours) 0.0020 ± .0002 n.d.c 0.080 ± .007
JC01(DE3) atoBCT5 fadBCT5 ΔfadA ΔfadE pETDuet 0.0016 ± .00002 -- --
JC01(DE3) atoBCT5 fadBCT5 ΔfadA ΔydiO pETDuet 0.0018 ± .0001 -- --
JC01(DE3) atoBCT5 fadBCT5 ΔfadA ΔcaiA pETDuet 0.0011 ± .0001 -- --
JC01(DE3) atoBCT5 fadBCT5 ΔfadA ΔaidB pETDuet 0.0026 ± .00003 -- --
JC01(DE3) atoBCT5 fadBCT5 ΔfadA pETDuet-fadE 0.019 ± .002 -- --
pETDuet-ydiO 0.0031 ± .0003 -- --
pETDuet-caiA 0.0014 ± .0002 -- --
pETDuet-egTER -- 3.1 ± 0.4 --
pETDuet-fabI -- 0.5 ± 0.05 3.4 ± .27
pETDuet-effabK -- 0.05 ± .010 0.14 ± .01
pETDuet-bsfabL -- n.d.c 0.019 ± .006
pETDuet-vcfabV -- 0.053 ± .010 4.3 ± 1.6
JC01(DE3) atoBCT5 fadBCT5 ΔfadA ΔfabI pETDuet-fabI 0.0010 ± .0032 0.14 ± .006 1.8 ± .10
pETDuet-bsfabL 0.0020 ± .0002 n.d. n.d.
aUnless indicated, all activities measured from 48 hr fermentation samples. 538
bConcentration of crotonyl-CoA used in enzymatic assay. 539
c No NADPH dependent trans-enoyl-CoA reductase activity detected. 540
‘--‘ Not Measured. ‘n.d’ Not Detected. 541
542
543
544
545
546
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
27
REFERENCES 547
1. Lee JW, Na D, Park JM, Lee J, Choi S, Lee SY. 2012. Systems metabolic engineering of 548
microorganisms for natural and non-natural chemicals. Nat. Chem. Biol. 8:536-546. 549
2. Quin MB, Schmidt-Dannert C. 2014. Designer microbes for biosynthesis. Curr. Opin. 550
Biotechnol. 29:55-61. 551
3. Peralta-Yahya PP, Zhang F, del Cardayre SB, Keasling JD. 2012. Microbial engineering 552
for the production of advanced biofuels. Nature 488:320-328. 553
4. Wen M, Bond-Watts BB, Chang MCY. 2013. Production of advanced biofuels in 554
engineered E. coli. Curr. Opin. Chem. Biol. 17:472-479. 555
5. Buchholz K, Collins J. 2013. The roots-a short history of industrial microbiology and 556
biotechnology. Appl. Microbiol. Biotechnol. 97:3747-3762. 557
6. Atsumi S, Cann AF, Connor MR, Shen CR, Smith KM, Brynildsen MP, Chou KJY, 558
Hanai T, Liao JC. 2008. Metabolic engineering of Escherichia coli for 1-butanol 559
production. Metab. Eng. 10:305–311. 560
7. Leonard E, Ajikumar PK, Thayer K, Xiao WH, Mo JD, Tidor B, Stephanopoulos G, 561
Prather KLJ. 2010. Combining metabolic and protein engineering of a terpenoid 562
biosynthetic pathway for overproduction and selectivity control. Proc. Natl. Acad. Sci. 563
U.S.A. 107:13654-13659. 564
8. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, 565
Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell 566
MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ. 2012. Production of 567
amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the 568
antimalarial agent artemisinin. Proc. Natl. Acad. Sci. U.S.A. 109:111-118. 569
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
28
9. Atsumi S, Hanai T, Liao JC. 2008. Non-fermentative pathways for synthesis of branched-570
chain higher alcohols as biofuels. Nature 451:86-U13. 571
10. Zhang KC, Sawaya MR, Eisenberg DS, Liao JC. 2008. Expanding metabolism for 572
biosynthesis of nonnatural alcohols. Proc. Natl. Acad. Sci. U.S.A. 105:20653-20658. 573
11. Steen EJ, Kang YS, Bokinsky G, Hu ZH, Schirmer A, McClure A, del Cardayre SB, 574
Keasling JD. 2010. Microbial production of fatty-acid-derived fuels and chemicals from 575
plant biomass. Nature 463:559-U182. 576
12. Schirmer A, Rude MA, Li XZ, Popova E, del Cardayre SB. 2010. Microbial Biosynthesis 577
of Alkanes. Science 329:559-562. 578
13. Janßen HJ, Steinbüchel A. 2014. Fatty acid synthesis in Escherichia coli and its 579
applications towards the production of fatty acid based biofuels. Biotechnol. Biofuels 7:26. 580
14. Lennen RM, Pfleger BF. 2012. Engineering Escherichia coli to synthesize free fatty acids. 581
Trends Biotechnol. 30:659-667. 582
15. Nawabi P, Bauer S, Kyrpides N, Lykidis A. 2011. Engineering Escherichia coli for 583
Biodiesel Production Utilizing a Bacterial Fatty Acid Methyltransferase. Appl. Environ. 584
Microbiol. 77:8052-8061. 585
16. Zhang FZ, Carothers JM, Keasling JD. 2012. Design of a dynamic sensor-regulator 586
system for production of chemicals and fuels derived from fatty acids. Nat. Biotechnol. 587
30:354-U166. 588
17. Bergler H, Wallner P, Ebeling A, Leitinger B, Fuchsbichler S, Aschauer H, Kollenz G, 589
Hogenauer G, Turnowsky F. 1994. Protein EnvM is the NADH-depdendent enoyl-ACP 590
reductase (FabI) of Escherichia coli. J. Biol. Chem. 269:5493-5496. 591
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
29
18. Bi HK, Zhu L, Wang HH, Cronan JE. 2014. Inefficient Translation Renders the 592
Enterococcus faecalis fabK Enoyl-Acyl Carrier Protein Reductase Phenotypically Cryptic. J. 593
Bacteriol. 196:170-179. 594
19. Heath RJ, Su N, Murphy CK, Rock CO. 2000. The enoyl- acyl-carrier-protein reductases 595
FabI and FabL from Bacillus subtilis. J. Biol. Chem. 275:40128-40133. 596
20. Massengo-Tiasse RP, Cronan JE. 2008. Vibrio cholerae FabV defines a new class of 597
enoyl-acyl carrier protein reductase. J. Biol. Chem. 283:1308-1316. 598
21. Clomburg JM, Vick JE, Blankschien MD, Rodriguez-Moya M, Gonzalez R. 2012. A 599
Synthetic Biology Approach to Engineer a Functional Reversal of the β-Oxidation Cycle. 600
ACS Synth. Biol. 1:541-554. 601
22. Dellomonaco C, Clomburg JM, Miller EN, Gonzalez R. 2011. Engineered reversal of the 602
β-oxidation cycle for the synthesis of fuels and chemicals. Nature 476:355-U131. 603
23. Kang YS, Durfee T, Glasner JD, Qiu Y, Frisch D, Winterberg KM, Blattner FR. 2004. 604
Systematic mutagenesis of the Escherichia coli genome. J. Bacteriol. 186:8548-8548. 605
24. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, 606
Cold Spring Harbor, NY. 607
25. Yazdani SS, Gonzalez R. 2008. Engineering Escherichia coli for the efficient conversion of 608
glycerol to ethanol and co-products. Metab. Eng. 10:340-351. 609
26. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, 610
Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene 611
knockout mutants: the Keio collection. Mol. Syst. Biol. 2:11. 612
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
30
27. Yu DG, Ellis HM, Lee EC, Jenkins NA, Copeland NG, Court DL. 2000. An efficient 613
recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. 614
Sci. U.S.A. 97:5978-5983. 615
28. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, Toyonaga H, Mori 616
H. 2005. Complete set of ORF clones of Escherichia coli ASKA library (A complete Set of 617
E. coli K-12 ORF archive): Unique resources for biological research. DNA Res. 12:291-299. 618
29. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in 619
Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 97:6640-6645. 620
30. Choi YJ, Morel L, Le Francois T, Bourque D, Bourget L, Groleau D, Massie B, Miguez 621
CB. 2010. Novel, Versatile, and Tightly Regulated Expression System for Escherichia coli 622
Strains. Appl. Environ. Microbiol. 76:5058-5066. 623
31. Vick JE, Johnson ET, Choudhary S, Bloch SE, Lopez-Gallego F, Srivastava P, Tikh IB, 624
Wawrzyn GT, Schmidt-Dannert C. 2011. Optimized compatible set of BioBrick (TM) 625
vectors for metabolic pathway engineering. Appl. Microbiol. Biotechnol. 92:1275-1286. 626
32. Thomason L, Court DL, Bubunenko M, Costantino N, Wilson H, Datta S, Oppenheim 627
A. 2007. Recombineering: genetic engineering in bacteria using homologous recombination, 628
Curr. Protoc. Mol. Biol. Chapter 1:Unit 1.16. 629
33. Magner DB, Blankschien MD, Lee JA, Pennington JM, Lupski JR, Rosenberg SM. 630
2007. RecQ promotes toxic recombination in cells lacking recombination intermediate-631
removal proteins. Mol. Cell 26:273-286. 632
34. Neidhardt FC, Bloch PL, Smith DF. 1974. Culture Medium for Enterobacteria. J. 633
Bacteriol. 119:736-747. 634
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
31
35. Mazumdar S, Blankschien MD, Clomburg JM, Gonzalez R. 2013. Efficient synthesis of 635
L-lactic acid from glycerol by metabolically engineered Escherichia coli. Microb. Cell Fact. 636
12:7. 637
36. Bond-Watts BB, Bellerose RJ, Chang MCY. 2011. Enzyme mechanism as a kinetic control 638
element for designing synthetic biofuel pathways. Nat. Chem. Biol. 7:222-227. 639
37. O’Brien WJ, Frerman FE. 1977. Evidence for a complex of 3 β-oxidation enzymes in 640
Escherichia coli- Induction and localization. J. Bacteriol. 132:532-540. 641
38. Campbell JW, Cronan JE. 2002. The enigmatic Escherichia coli fadE gene is yafH. J. 642
Bacteriol. 184:3759-3764. 643
39. Campbell JW, Morgan-Kiss RM, Cronan JE. 2003. A new Escherichia coli metabolic 644
competency: growth on fatty acids by a novel anaerobic β-oxidation pathway. Mol. 645
Microbiol. 47:793-805. 646
40. Preusser A, Wagner U, Elssner T, Kleber HP. 1999. Crotonobetaine reductase from 647
Escherichia coli consists of two proteins. Biochim. Biophys. Acta. 1431:166-178. 648
41. Elssner T, Hennig L, Frauendorf H, Haferburg D, Kleber HP. 2000. Isolation, 649
identification, and synthesis of gamma-butyrobetainyl-CoA and crotonobetainyl-CoA, 650
compounds involved in carnitine metabolism of E. coli. Biochemistry 39:10761-10769. 651
42. Landini P, Hajec LI, Volkert MR. 1994. Structure and transcriptional regulation of the 652
Escherichia coli adaptive response gene aidB. J. Bacteriol. 176:6583-6589. 653
43. Rohankhedkar MS, Mulrooney SB, Wedemeyer WJ, Hausinger RP. 2006. The AidB 654
component of the Escherichia coli adaptive response to alkylating agents is a flavin-655
containing, DNA-binding protein. J. Bacteriol. 188:223-230. 656
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
32
44. Heath RJ, Rock CO. 1995. Enoyl-acyl carrier protein reductase (FabI) plays a determinant 657
role in completing cycles of fatty acid elongation in Escherichia coli. J. Biol. Chem. 658
270:26538-26542. 659
45. Bergler H, Fuchsbichler S, Hogenauer G, Turnowsky F. 1996. The enoyl- acyl-carrier-660
protein reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty 661
acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-662
CoA. Eur. J. Biochem. 242:689-694. 663
46. Weeks G, Wakil SJ. 1968. Studies on mechanism of fatty acid synthesis: Preparation and 664
general properties of enoyl acyl carrier protein reductases from Escherichia coli. J. Biol. 665
Chem. 243:1180-9. 666
47. Zhu L, Bi HK, Ma JC, Hu Z, Zhang WB, Cronan JE, Wang HH. 2013. The Two 667
Functional Enoyl-Acyl Carrier Protein Reductases of Enterococcus faecalis Do Not Mediate 668
Triclosan Resistance. MBio 4:10. 669
48. Ishihama Y, Schmidt T, Rappsilber J, Mann M, Hartl FU, Kerner MJ, Frishman D. 670
2008. Protein abundance profiling of the Escherichia coli cytosol. BMC Genomics 9:17. 671
49. Taguchi S, Yamadaa M, Matsumoto K, Tajima K, Satoh Y, Munekata M, Ohno K, 672
Kohda K, Shimamura T, Kambe H, Obata S. 2008. A microbial factory for lactate-based 673
polyesters using a lactate-polymerizing enzyme. Proc. Natl. Acad. Sci. U.S.A. 105:17323-674
17327. 675
50. Tseng HC, Prather KLJ. 2012. Controlled biosynthesis of odd-chain fuels and chemicals 676
via engineered modular metabolic pathways. Proc. Natl. Acad. Sci. U.S.A. 109:17925-677
17930. 678
on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
33
51. Binstock JF, Schulz H. 1981. Fatty acid oxidation complex from Escherichia coli. Methods 679
Enzymol. 71 Pt C:403-411. 680
52. Jenkins LS, Nunn WD. 1987. Genetic and molecular characterization of the genes involved 681
in short-chain fatty-acid degradation in Escherichia coli: The ato system. J. Bacteriol. 682
169:42-52. 683
53. White SW, Zheng J, Zhang YM, Rock CO. 2005. The structural biology of type II fatty 684
acid biosynthesis, p. 791-831, Annual Review of Biochemistry, vol. 74. Annual Reviews, 685
Palo Alto. 686
54. Akhtar MK, Jones PR. 2009. Construction of a synthetic YdbK-dependent pyruvate:H-2 687
pathway in Escherichia coli BL21(DE3). Metab. Eng. 11:139-147. 688
55. Cintolesi A, Clomburg JM, Gonzalez R. 2014. In silico assessment of the metabolic 689
capabilities of an engineered functional reversal of the beta-oxidation cycle for the synthesis 690
of longer-chain (C >= 4) products. Metab. Eng. 23:100-115. 691 on January 21, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from